Karin Przyklenk obtained her Ph.D. degree in biophysics from the University of Western Ontario (London, Ont, Canada). She was a Postdoctoral Fellow at Harvard (Boston, Mass, USA), and held faculty appointments at Good Samaritan Hospital, University of Southern California (Los Angeles, Calif, USA) and the University of Massachusetts Medical School (Worcester, Mass, USA) before being recruited to serve as the Director of the Cardiovascular Research Institute, Wayne State University School of Medicine (Detroit, Mich, USA). Her research focuses on the pathophysiology of acute coronary ischemic syndromes, the identification of cellular mechanisms and signaling pathways that increase the tolerance of the myocardium to ischemia, and the development of novel strategies to limit the damage caused to the heart by ischemia-reperfusion. She has authored more than 180 peer-reviewed papers, invited reviews, editorials, and book chapters in the field of myocardial ischemia and infarction, she is on the Editorial Board of multiple journals, and she has been a Grant Reviewer for the National Institutes of Health (NIH), the American Heart Association, as well as the Biomedical Research Council of Singapore and the Wellcome Trust (UK).
Biography Updated on 1 July 2009